Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

PubWeight™: 3.74‹?› | Rank: Top 1%

🔗 View Article (PMID 56646)

Published in Lancet on April 17, 1976

Authors

T E Starzl, K Watanabe, K A Porter, C W Putnam

Articles citing this

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61

Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35

Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31

Animal research in liver transplantation with special reference to the dog. Semin Liver Dis (1985) 2.28

The hepatotropic influence of cyclosporine. Surgery (1990) 2.27

Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci U S A (1976) 2.23

Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78

Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72

The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32

Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology (1987) 1.30

Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology (1991) 1.30

The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. Transplantation (1991) 1.24

Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology (1987) 1.24

Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med (1996) 1.16

Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc (1990) 1.14

The effect upon the liver of evisceration with or without hormone replacement. Surg Gynecol Obstet (1978) 1.11

Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. Transplantation (1991) 1.01

Portacaval transposition and subsequent partial hepatectomy in the rat: effects on liver atrophy, hypertrophy and regenerative hyperplasia. Br J Exp Pathol (1977) 1.01

Further steps of hepatic stimulatory substance purification. Dig Dis Sci (1991) 1.01

Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. Am J Pathol (1997) 1.01

Themes of liver transplantation. Hepatology (2010) 0.98

Hepatic blood flow studies in the rat before and after portacaval transposition. Br J Exp Pathol (1978) 0.94

Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern. Am J Pathol (1996) 0.93

Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen. Proc Natl Acad Sci U S A (1988) 0.92

Evidence for liver cell proliferation during fatal acute liver failure. Gut (1980) 0.90

Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology (1992) 0.89

Liver transplantation for type I and type IV glycogen storage disease. Eur J Pediatr (1993) 0.89

Hepatic regeneration: implications in fulminant hepatic failure. Int J Artif Organs (1979) 0.89

The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage. Int J Gen Med (2011) 0.89

Portal circulation and portal hypertension. Gut (1978) 0.89

Regulation of liver size and regeneration: importance in liver transplantation. Transplant Proc (1988) 0.88

Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol (2002) 0.88

The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo. Transplant Proc (1991) 0.84

Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration. Metabolism (1976) 0.82

Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy. Hepatology (1983) 0.80

Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology (1993) 0.80

Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology (1994) 0.79

Ultrastructural characteristics of hyperplastic alterations in the liver of congenital portacaval-shunt rats. Br J Exp Pathol (1984) 0.79

Liver blood flow measurements in the portacavally transposed rat before and after partial hepatectomy. Br J Exp Pathol (1978) 0.79

Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1. Transplant Proc (1992) 0.78

Liver transplantation. Gastroenterology (1997) 0.78

Changes in the nuclei of astrocytes following portacaval shunting and portacaval transposition in the rat. Br J Exp Pathol (1978) 0.78

Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. Lancet (1983) 0.78

Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo. Hepatology (1991) 0.77

The role of hepatotrophic factors in liver regeneration--a brief review including a preliminary report of the in vitro effects of hepatic regenerative stimulator substance (SS). Yale J Biol Med (1979) 0.77

Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy. Surg Today (1998) 0.77

Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. Transplantation (1991) 0.76

The effect of different types of hepatic injury on the estrogen and androgen receptor activity of liver. J Invest Surg (1989) 0.75

World's longest surviving liver-pancreas recipient. Liver Transpl (2007) 0.75

Cellular transplantation and gene therapy. Clin Transplant (1993) 0.75

The ripple effect of liver transplantation. Transplant Proc (1980) 0.75

The transplantation of gastrointestinal organs. Gastroenterology (1993) 0.75

A case of pulmonary arterial hypertension associated with congenital extrahepatic portocaval shunt. J Korean Med Sci (2014) 0.75

The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75

Hepatic Regeneration. Viewp Dig Dis (1979) 0.75

Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms. Mol Med (2015) 0.75

The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions. Surg Today (2000) 0.75

Effects of tacrolimus and insulin in a liver regeneration model in growing animals with portal vein stenosis: immunohistochemical and molecular studies. Pediatr Surg Int (2014) 0.75

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

Loop-mediated isothermal amplification of DNA. Nucleic Acids Res (2000) 19.30

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Boron nitride substrates for high-quality graphene electronics. Nat Nanotechnol (2010) 9.72

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med (2000) 4.99

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Mobilization of transposons by a mutation abolishing full DNA methylation in Arabidopsis. Nature (2001) 4.71

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Recent evidence for evolution of the genetic code. Microbiol Rev (1992) 4.32

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Massive Dirac fermions and Hofstadter butterfly in a van der Waals heterostructure. Science (2013) 3.79

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Expansive open-door laminoplasty for cervical spinal stenotic myelopathy. Spine (Phila Pa 1976) (1983) 3.53

Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit. J Clin Microbiol (1994) 3.51

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol (1998) 3.34

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15